195 related articles for article (PubMed ID: 25238546)
1. AKT1 and SELP polymorphisms predict the risk of developing cachexia in pancreatic cancer patients.
Avan A; Avan A; Le Large TY; Mambrini A; Funel N; Maftouh M; Ghayour-Mobarhan M; Cantore M; Boggi U; Peters GJ; Pacetti P; Giovannetti E
PLoS One; 2014; 9(9):e108057. PubMed ID: 25238546
[TBL] [Abstract][Full Text] [Related]
2. Association of MTOR and AKT Gene Polymorphisms with Susceptibility and Survival of Gastric Cancer.
Piao Y; Li Y; Xu Q; Liu JW; Xing CZ; Xie XD; Yuan Y
PLoS One; 2015; 10(8):e0136447. PubMed ID: 26317520
[TBL] [Abstract][Full Text] [Related]
3. Interaction between SELP genetic polymorphisms with inflammatory cytokine interleukin-6 (IL-6) gene variants on cardiovascular disease in Chinese Han population.
Kou L; Yang N; Dong B; Li Y; Yang J; Qin Q
Mamm Genome; 2017 Oct; 28(9-10):436-442. PubMed ID: 28819827
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between -2028 C/T SELP Gene Polymorphism, Concentration of Plasma P-Selectin and Risk of Malnutrition in Head and Neck Cancer Patients.
Powrózek T; Mlak R; Brzozowska A; Mazurek M; Gołębiowski P; Małecka-Massalska T
Pathol Oncol Res; 2019 Apr; 25(2):741-749. PubMed ID: 30617759
[TBL] [Abstract][Full Text] [Related]
5. Association of SELP Polymorphisms with Soluble P-Selectin Levels and Vascular Risk in Patients with Type 2 Diabetes Mellitus: A Case-Control Study.
Kaur R; Singh J; Kapoor R; Kaur M
Biochem Genet; 2019 Feb; 57(1):73-97. PubMed ID: 30047017
[TBL] [Abstract][Full Text] [Related]
6. P-selectin genotype is associated with the development of cancer cachexia.
Tan BH; Fladvad T; Braun TP; Vigano A; Strasser F; Deans DA; Skipworth RJ; Solheim TS; Damaraju S; Ross JA; Kaasa S; Marks DL; Baracos VE; Skorpen F; Fearon KC;
EMBO Mol Med; 2012 Jun; 4(6):462-71. PubMed ID: 22473907
[TBL] [Abstract][Full Text] [Related]
7. The differential effects of sarcopenia and cachexia on overall survival for pancreatic ductal adenocarcinoma patients following pancreatectomy: A retrospective study based on a large population.
Shen XD; Wang X; Zheng ZJ; Chen YH; Tan CL; Liu XB; Ke NW
Cancer Med; 2023 May; 12(9):10438-10448. PubMed ID: 36938648
[TBL] [Abstract][Full Text] [Related]
8. Role of noncoding RNAs in pancreatic ductal adenocarcinoma associated cachexia.
Uddin MH; Mohammad RM; Philip PA; Azmi AS; Muqbil I
Am J Physiol Cell Physiol; 2022 Dec; 323(6):C1624-C1632. PubMed ID: 36280389
[TBL] [Abstract][Full Text] [Related]
9. Osteopenia is associated with wasting in pancreatic adenocarcinoma and predicts survival after surgery.
Cameron ME; Underwood PW; Williams IE; George TJ; Judge SM; Yarrow JF; Trevino JG; Judge AR
Cancer Med; 2022 Jan; 11(1):50-60. PubMed ID: 34791809
[TBL] [Abstract][Full Text] [Related]
10. Phosph-Akt1 expression is associated with a favourable prognosis in pancreatic cancer.
Liu J; Cheng Sun SH; Sun SJ; Huang C; Hu HH; Jin YB; Qiu ZJ
Ann Acad Med Singap; 2010 Jul; 39(7):548-7. PubMed ID: 20697673
[TBL] [Abstract][Full Text] [Related]
11. Incidence and frequency of cancer cachexia during chemotherapy for advanced pancreatic ductal adenocarcinoma.
Mitsunaga S; Kasamatsu E; Machii K
Support Care Cancer; 2020 Nov; 28(11):5271-5279. PubMed ID: 32103356
[TBL] [Abstract][Full Text] [Related]
12. Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.
Gerber MH; Underwood PW; Judge SM; Delitto D; Delitto AE; Nosacka RL; DiVita BB; Thomas RM; Permuth JB; Hughes SJ; Wallet SM; Judge AR; Trevino JG
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513792
[TBL] [Abstract][Full Text] [Related]
13. Primate-specific miRNA-637 inhibited tumorigenesis in human pancreatic ductal adenocarcinoma cells by suppressing Akt1 expression.
Xu RL; He W; Tang J; Guo W; Zhuang P; Wang CQ; Fu WM; Zhang JF
Exp Cell Res; 2018 Feb; 363(2):310-314. PubMed ID: 29366808
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
Riner AN; Herremans KM; Vudatha V; Han S; Qu X; Liu J; Mukhopadhyay N; Freudenberger DC; George TJ; Judge SM; Judge AR; Hughes SJ; Trevino JG
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):149-158. PubMed ID: 38123146
[TBL] [Abstract][Full Text] [Related]
15. The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes.
Li X; Zhang R; Liu Z; Li S; Xu H
Oncotarget; 2017 Mar; 8(12):20252-20265. PubMed ID: 28423632
[TBL] [Abstract][Full Text] [Related]
16. Impact of
Zubair H; Khan Z; Imran M
Radiol Oncol; 2022 Aug; 56(3):336-345. PubMed ID: 35962953
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors.
Zhang X; Fan J; Li Y; Lin S; Shu P; Ni J; Qin S; Zhang Z
Tumour Biol; 2016 Jan; 37(1):1061-9. PubMed ID: 26269114
[TBL] [Abstract][Full Text] [Related]
18. Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.
Ozola Zalite I; Zykus R; Francisco Gonzalez M; Saygili F; Pukitis A; Gaujoux S; Charnley RM; Lyadov V
Pancreatology; 2015; 15(1):19-24. PubMed ID: 25524484
[TBL] [Abstract][Full Text] [Related]
19. Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer.
Prokopchuk O; Grünwald B; Nitsche U; Jäger C; Prokopchuk OL; Schubert EC; Friess H; Martignoni ME; Krüger A
BMC Cancer; 2018 Feb; 18(1):128. PubMed ID: 29394913
[TBL] [Abstract][Full Text] [Related]
20. Association of IL-6 gene polymorphisms with cachexia susceptibility and survival time of patients with pancreatic cancer.
Zhang D; Zhou Y; Wu L; Wang S; Zheng H; Yu B; Li J
Ann Clin Lab Sci; 2008; 38(2):113-9. PubMed ID: 18469355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
